Galapagos NV
GLPG
#4560
Rank
C$2.92 B
Marketcap
C$43.82
Share price
0.44%
Change (1 day)
15.65%
Change (1 year)

Galapagos NV (GLPG) - Total assets

Total assets on the balance sheet as of September 2025 : C$5.70 Billion

According to Galapagos NV's latest financial reports the company's total assets are C$5.70 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Galapagos NV - Total assets on balance sheet (from 2008 to 2025)

Total assets by year

Year Total assets Change
2024-12-31C$6.17 B-3.34%
2023-12-31C$6.38 B-7.29%
2022-12-31C$6.89 B-8.06%
2021-12-31C$7.49 B-16.41%
2020-12-31C$8.96 B0.99%
2019-12-31C$8.87 B295.81%
2018-12-31C$2.24 B15.61%
2017-12-31C$1.94 B26.71%
2016-12-31C$1.53 B128.15%
2015-12-31C$0.67 B75.83%
2014-12-31C$0.38 B-9.64%
2013-12-31C$0.42 B36.48%
2012-12-31C$0.30 B45.49%
2011-12-31C$0.21 B-17.5%
2010-12-31C$0.25 B19.04%
2009-12-31C$0.21 B7.26%
2008-12-31C$0.20 B-6.76%
2007-12-31C$0.21 B-15.89%
2006-12-31C$0.25 B128.96%
2005-12-31C$0.11 B342.21%
2004-12-31C$25.43 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
AstraZeneca
AZN
C$158.55 B 2,677.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
C$267.11 B 4,578.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$211.01 B 3,595.81%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
C$185.49 B 3,148.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
C$0.22 B-96.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$116.61 B 1,942.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$55.21 B 867.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
C$114.23 B 1,900.72%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
C$179.46 B 3,043.15%๐Ÿ‡บ๐Ÿ‡ธ USA